Home
GSK reported a 16.4% stake in Spero Therapeutics SPRO · 9,190,606 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 16.4%
- Last report
- No earlier report
- Shares held
- 9,190,606 sh
- Class
- Common Stock, Par Value $0.001
- Holder
- GSK
- Event date
- 25/03/27
- Filed
- 25/03/28
16.4% stake
Spero Therapeutics trades, last 26 weeks
What else happened in Spero Therapeutics around then
Filed or reported within 30 days of the trade day · 25/02/25~25/04/26GSK's other 5% stake reports
No other trades yet.